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Conclusions: The measurement in Alderson phantom is 
presumed to give most accurate estimate, even though the 
real patient dimensions may differ. For situations where the 
first estimates indicate doses >100 mSv it should be 
considered to do a low dose CT scan of the patient and 
transfer to the dose planning system. When the distance from 
uterus to lower field limit is less than 20cm the dose planning 
system seems to be quite accurate.  
Such cases need to be carefully considered by the clinical 
team in the hospital; the patient and family members need 
evidence based medical advises in this difficult ethical 
dilemma. In this case there was no indication for abortus 
provocatus due to the radiation dose itself. 
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Purpose/Objective: Oncoplastic surgery has become more 
frequent in the last few years, because of excellent cosmetic 
results. Adjuvant radiotherapy procedures have to cope with 
breast tissue displacements in the postoperative target 
definition. 
The purpose is to present our methodology for image guided 
HDR interstitial Brachytherapy of breast cancer, based on 
localize stereotactically the target volume and doing the 
implant image-guided to better fit its volume. 
Materials and Methods: 20 breast cancer patients (10 T1 and 
10 T2, median size 17.5mm) treated with post-operative 
image guided brachytherapy (IGBT), 19 were boost before 
external RT (18 cases 7Gy-1 session, and 1 case 5Gy-3 
sessions), and one was exclusive treatment (4Gy-8 sessions). 
Computed Tomography (CT) Phillips BrillianceTM, treatment 
planning systems (TPS) Pinnacle³ TM (external) and Elekta 
OncentraTM Brachy (brachytherapy), Linear Accelerator Varian 
Clinac TM 2100C/D, and HDR delivery system Elekta 
microSelectronTM with Elekta COMFORTTM Catheter Applicator 
System. 
The starting point was a CT with the patient in a favorable 
position for the catheter implantation and fixed using a 
vacuum cushion for head and shoulders. Using Pinnacle³ TM as 
a virtual simulator two opposite beams were defined, 
collimated to the PTV, and with gantry angles that satisfy 
(figure below): 
- Anatomically feasible geometry for the implant (possibility 
of covering the PTV without crossing with the needles the 
chest wall plus a 6mm margin) 
- Minimum PTV section and exposed skin area, with the least 
healthy tissue crossed by needles (minimizing the number of 
catheters) 
Also the length should be less than 20cm in every possible 
catheter path (maximum needle length). Depending on the 
BEV area, the number of catheters was decided. 
A set of representatives points for the BEV perimeter were 
chosen, and their 3D coordinates registered (relative to the 
point marked by tattoos in the CT). Using the Clinac as a 
simulator, all these couch displacements were made, and so 
all the points were marked on the skin. These marks were the 
guidance for the implant process (it enclosed the entrance & 
exit points). After the implant, a new CT was made to check 
the needle setting, allowing for corrections if there are PTV 
areas far from any needle (6mm). Finally, the treatment was 
planned with OncentraTM Brachy, 3D criteria, and graphical 
optimization. 
 
 
Results: The mean PTV size was 43.2cc and the mean number 
of catheters was 9. The dosimetric results were analyzed by 
some quality parameters: 
- For the PTV the D90, homogeneity (DHI=1- V150/V100), and 
conformity index (RTOG-CI). 
- For the OARs (skin and chest wall), the volume exposed at 
doses greater than 70% of the prescribed dose. 
 
Conclusions: We obtained good results for the CI and DHI 
parameters, keeping the V70% for OAR’s at clinically 
optimized levels. 
